questionsmedicales.fr
Composés hétérocycliques
Composés hétérocycliques à cycles fusionnés
Composés hétérocycliques avec 4 noyaux ou plus
Ergotamines
Ergotamines : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Migraine
Diagnostic médical
Imagerie par résonance magnétique
Migraine
Critères diagnostiques
Migraine
Antécédents familiaux
Migraine
Symptômes
5
Variabilité des symptômes
Migraine
Prévention
5
Prévention des migraines
Déclencheurs de migraine
Régime alimentaire
Migraine
Exercice physique
Migraine
Thérapies alternatives
Migraine
Traitements
5
Ergotamines
Traitement de la migraine
Effets secondaires
Ergotamines
Efficacité du traitement
Ergotamines
Interactions médicamenteuses
Ergotamines
Voie d'administration
Ergotamines
Complications
5
Accident vasculaire cérébral
Migraine
Migraine chronique
Qualité de vie
Fonction cognitive
Migraine
Gestion des complications
Migraine
Facteurs de risque
5
Facteurs de risque
Migraine
Fluctuations hormonales
Migraine
Habitudes alimentaires
Migraine
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Ergotamines : Questions médicales les plus fréquentes",
"headline": "Ergotamines : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Ergotamines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-26",
"dateModified": "2025-03-21",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Ergotamines"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Composés hétérocycliques avec 4 noyaux ou plus",
"url": "https://questionsmedicales.fr/mesh/D006576",
"about": {
"@type": "MedicalCondition",
"name": "Composés hétérocycliques avec 4 noyaux ou plus",
"code": {
"@type": "MedicalCode",
"code": "D006576",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.400"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Bromocriptine",
"alternateName": "Bromocriptine",
"url": "https://questionsmedicales.fr/mesh/D001971",
"about": {
"@type": "MedicalCondition",
"name": "Bromocriptine",
"code": {
"@type": "MedicalCode",
"code": "D001971",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.400.562.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dihydroergocornine",
"alternateName": "Dihydroergocornine",
"url": "https://questionsmedicales.fr/mesh/D025441",
"about": {
"@type": "MedicalCondition",
"name": "Dihydroergocornine",
"code": {
"@type": "MedicalCode",
"code": "D025441",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.400.562.150"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dihydroergocristine",
"alternateName": "Dihydroergocristine",
"url": "https://questionsmedicales.fr/mesh/D025442",
"about": {
"@type": "MedicalCondition",
"name": "Dihydroergocristine",
"code": {
"@type": "MedicalCode",
"code": "D025442",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.400.562.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "alpha-Dihydroergocryptine",
"alternateName": "Dihydroergocryptine",
"url": "https://questionsmedicales.fr/mesh/D025443",
"about": {
"@type": "MedicalCondition",
"name": "alpha-Dihydroergocryptine",
"code": {
"@type": "MedicalCode",
"code": "D025443",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.400.562.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dihydroergotamine",
"alternateName": "Dihydroergotamine",
"url": "https://questionsmedicales.fr/mesh/D004087",
"about": {
"@type": "MedicalCondition",
"name": "Dihydroergotamine",
"code": {
"@type": "MedicalCode",
"code": "D004087",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.400.562.300"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dihydroergotoxine",
"alternateName": "Dihydroergotoxine",
"url": "https://questionsmedicales.fr/mesh/D004088",
"about": {
"@type": "MedicalCondition",
"name": "Dihydroergotoxine",
"code": {
"@type": "MedicalCode",
"code": "D004088",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.400.562.400"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Mésilate d'alcaloïdes hydrogénés de l'ergot",
"alternateName": "Ergoloid Mesylates",
"url": "https://questionsmedicales.fr/mesh/D004877",
"about": {
"@type": "MedicalCondition",
"name": "Mésilate d'alcaloïdes hydrogénés de l'ergot",
"code": {
"@type": "MedicalCode",
"code": "D004877",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.400.562.400.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Ergotamine",
"alternateName": "Ergotamine",
"url": "https://questionsmedicales.fr/mesh/D004878",
"about": {
"@type": "MedicalCondition",
"name": "Ergotamine",
"code": {
"@type": "MedicalCode",
"code": "D004878",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.400.562.500"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Ergotamines",
"alternateName": "Ergotamines",
"code": {
"@type": "MedicalCode",
"code": "D004879",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Manoj B Kudupoje",
"url": "https://questionsmedicales.fr/author/Manoj%20B%20Kudupoje",
"affiliation": {
"@type": "Organization",
"name": "Chemistry and Toxicology Division, Center for animal Nutrigenomics & Applied Animal Nutrition, Alltech Inc., 3031 Catnip Hill Road, Nicholasville, Kentucky 40356, United States."
}
},
{
"@type": "Person",
"name": "Eric S Vanzant",
"url": "https://questionsmedicales.fr/author/Eric%20S%20Vanzant",
"affiliation": {
"@type": "Organization",
"name": "Department of Animal and Food Sciences, University of Kentucky, W.P. Garrigus Building, Lexington, Kentucky 40546-0215, United States."
}
},
{
"@type": "Person",
"name": "Kyle R McLeod",
"url": "https://questionsmedicales.fr/author/Kyle%20R%20McLeod",
"affiliation": {
"@type": "Organization",
"name": "Department of Animal and Food Sciences, University of Kentucky, W.P. Garrigus Building, Lexington, Kentucky 40546-0215, United States."
}
},
{
"@type": "Person",
"name": "Alexandros Yiannikouris",
"url": "https://questionsmedicales.fr/author/Alexandros%20Yiannikouris",
"affiliation": {
"@type": "Organization",
"name": "Chemistry and Toxicology Division, Center for animal Nutrigenomics & Applied Animal Nutrition, Alltech Inc., 3031 Catnip Hill Road, Nicholasville, Kentucky 40356, United States."
}
},
{
"@type": "Person",
"name": "Wiebke Rudolph",
"url": "https://questionsmedicales.fr/author/Wiebke%20Rudolph",
"affiliation": {
"@type": "Organization",
"name": "a Institute of Forensic Medicine , Jena University Hospital , Jena , Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Cognitive Training: A Field in Search of a Phenomenon.",
"datePublished": "2022-08-08",
"url": "https://questionsmedicales.fr/article/35939827",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/17456916221091830"
}
},
{
"@type": "ScholarlyArticle",
"name": "Combining exercise with cognitive training and vitamin D",
"datePublished": "2023-05-10",
"url": "https://questionsmedicales.fr/article/37162700",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11357-023-00805-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "Epigenetic modification related to cognitive changes during a cognitive training intervention in depression.",
"datePublished": "2023-07-27",
"url": "https://questionsmedicales.fr/article/37516234",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.pnpbp.2023.110835"
}
},
{
"@type": "ScholarlyArticle",
"name": "Long-term cognitive training enhances fluid cognition and brain connectivity in individuals with MCI.",
"datePublished": "2024-10-23",
"url": "https://questionsmedicales.fr/article/39443463",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41398-024-03153-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Sensory processing sensitivity, memory and cognitive training with neurofeedback.",
"datePublished": "2023-07-25",
"url": "https://questionsmedicales.fr/article/37499911",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.bbr.2023.114601"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés hétérocycliques",
"item": "https://questionsmedicales.fr/mesh/D006571"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés hétérocycliques à cycles fusionnés",
"item": "https://questionsmedicales.fr/mesh/D000072471"
},
{
"@type": "ListItem",
"position": 4,
"name": "Composés hétérocycliques avec 4 noyaux ou plus",
"item": "https://questionsmedicales.fr/mesh/D006576"
},
{
"@type": "ListItem",
"position": 5,
"name": "Ergotamines",
"item": "https://questionsmedicales.fr/mesh/D004879"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Ergotamines - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Ergotamines",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-12",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Ergotamines",
"description": "Comment diagnostiquer une migraine ?\nQuels tests sont utilisés pour les migraines ?\nLes ergots sont-ils prescrits pour d'autres maux de tête ?\nQuels critères sont utilisés pour le diagnostic ?\nLes antécédents familiaux influencent-ils le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D004879?mesh_terms=Cognitive+Training#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Ergotamines",
"description": "Quels sont les symptômes d'une migraine ?\nLes migraines provoquent-elles des vomissements ?\nY a-t-il des signes avant-coureurs de migraine ?\nLes migraines peuvent-elles causer des vertiges ?\nLes symptômes varient-ils d'une personne à l'autre ?",
"url": "https://questionsmedicales.fr/mesh/D004879?mesh_terms=Cognitive+Training#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Ergotamines",
"description": "Comment prévenir les migraines ?\nLes changements alimentaires aident-ils à prévenir les migraines ?\nLe stress influence-t-il la fréquence des migraines ?\nLes exercices physiques aident-ils à prévenir les migraines ?\nLes thérapies alternatives sont-elles efficaces ?",
"url": "https://questionsmedicales.fr/mesh/D004879?mesh_terms=Cognitive+Training#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Ergotamines",
"description": "Comment les ergots soulagent-ils les migraines ?\nQuels sont les effets secondaires des ergots ?\nLes ergots sont-ils efficaces pour tous les patients ?\nPeut-on combiner les ergots avec d'autres médicaments ?\nQuelle est la voie d'administration des ergots ?",
"url": "https://questionsmedicales.fr/mesh/D004879?mesh_terms=Cognitive+Training#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Ergotamines",
"description": "Quelles sont les complications possibles des migraines ?\nLes migraines peuvent-elles entraîner des AVC ?\nLes migraines chroniques ont-elles des conséquences ?\nLes migraines peuvent-elles causer des problèmes cognitifs ?\nComment gérer les complications des migraines ?",
"url": "https://questionsmedicales.fr/mesh/D004879?mesh_terms=Cognitive+Training#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Ergotamines",
"description": "Quels sont les facteurs de risque des migraines ?\nL'âge influence-t-il le risque de migraines ?\nLes changements hormonaux affectent-ils les migraines ?\nLe manque de sommeil est-il un facteur de risque ?\nLes habitudes alimentaires influencent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D004879?mesh_terms=Cognitive+Training#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une migraine ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique des symptômes et des examens neurologiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour les migraines ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests d'imagerie comme l'IRM peuvent être utilisés pour exclure d'autres causes."
}
},
{
"@type": "Question",
"name": "Les ergots sont-ils prescrits pour d'autres maux de tête ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont principalement prescrits pour les migraines, pas pour d'autres types de céphalées."
}
},
{
"@type": "Question",
"name": "Quels critères sont utilisés pour le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères incluent la fréquence, la durée et l'intensité des crises de migraine."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de migraines peuvent augmenter la probabilité de diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une migraine ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des douleurs pulsatiles, des nausées et une sensibilité à la lumière."
}
},
{
"@type": "Question",
"name": "Les migraines provoquent-elles des vomissements ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vomissements peuvent accompagner les migraines chez certains patients."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes avant-coureurs de migraine ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme des troubles visuels ou des picotements peuvent précéder une migraine."
}
},
{
"@type": "Question",
"name": "Les migraines peuvent-elles causer des vertiges ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines personnes ressentent des vertiges ou des étourdissements pendant une crise."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils d'une personne à l'autre ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et la nature des symptômes peuvent varier considérablement entre les individus."
}
},
{
"@type": "Question",
"name": "Comment prévenir les migraines ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les déclencheurs connus, maintenir un mode de vie sain et prendre des médicaments préventifs."
}
},
{
"@type": "Question",
"name": "Les changements alimentaires aident-ils à prévenir les migraines ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains aliments peuvent déclencher des migraines, leur évitement peut aider."
}
},
{
"@type": "Question",
"name": "Le stress influence-t-il la fréquence des migraines ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress est un déclencheur courant des migraines et sa gestion est cruciale."
}
},
{
"@type": "Question",
"name": "Les exercices physiques aident-ils à prévenir les migraines ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une activité physique régulière peut réduire la fréquence et l'intensité des migraines."
}
},
{
"@type": "Question",
"name": "Les thérapies alternatives sont-elles efficaces ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines thérapies comme l'acupuncture peuvent aider à réduire la fréquence des migraines."
}
},
{
"@type": "Question",
"name": "Comment les ergots soulagent-ils les migraines ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les ergots agissent en constrictant les vaisseaux sanguins et en réduisant l'inflammation."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des ergots ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure des nausées, des vertiges et des douleurs abdominales."
}
},
{
"@type": "Question",
"name": "Les ergots sont-ils efficaces pour tous les patients ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, leur efficacité peut varier et certains patients peuvent ne pas y répondre."
}
},
{
"@type": "Question",
"name": "Peut-on combiner les ergots avec d'autres médicaments ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, mais il est important de consulter un médecin pour éviter les interactions."
}
},
{
"@type": "Question",
"name": "Quelle est la voie d'administration des ergots ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les ergots peuvent être administrés par voie orale, nasale ou injectable selon le cas."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles des migraines ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des troubles de l'humeur, des problèmes de sommeil et des AVC."
}
},
{
"@type": "Question",
"name": "Les migraines peuvent-elles entraîner des AVC ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les migraines avec aura peuvent augmenter le risque d'accident vasculaire cérébral."
}
},
{
"@type": "Question",
"name": "Les migraines chroniques ont-elles des conséquences ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent affecter la qualité de vie et entraîner des troubles psychologiques."
}
},
{
"@type": "Question",
"name": "Les migraines peuvent-elles causer des problèmes cognitifs ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent que les migraines fréquentes peuvent affecter la cognition."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications des migraines ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une approche multidisciplinaire incluant médecins et psychologues est souvent nécessaire."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque des migraines ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, le sexe féminin, et le stress."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de migraines ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les migraines sont plus fréquentes chez les jeunes adultes et les femmes d'âge moyen."
}
},
{
"@type": "Question",
"name": "Les changements hormonaux affectent-ils les migraines ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les fluctuations hormonales, notamment pendant le cycle menstruel, peuvent déclencher des migraines."
}
},
{
"@type": "Question",
"name": "Le manque de sommeil est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le manque de sommeil peut augmenter la fréquence et l'intensité des migraines."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires influencent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains aliments et boissons peuvent déclencher des migraines chez certaines personnes."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 21/03/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Chemistry and Toxicology Division, Center for animal Nutrigenomics & Applied Animal Nutrition, Alltech Inc., 3031 Catnip Hill Road, Nicholasville, Kentucky 40356, United States.
Department of Animal and Food Sciences, University of Kentucky, W.P. Garrigus Building, Lexington, Kentucky 40546-0215, United States.
Publications dans "Ergotamines" :
2 publications dans cette catégorie
Affiliations :
Department of Animal and Food Sciences, University of Kentucky, W.P. Garrigus Building, Lexington, Kentucky 40546-0215, United States.
Publications dans "Ergotamines" :
2 publications dans cette catégorie
Affiliations :
Department of Animal and Food Sciences, University of Kentucky, W.P. Garrigus Building, Lexington, Kentucky 40546-0215, United States.
Publications dans "Ergotamines" :
2 publications dans cette catégorie
Affiliations :
Chemistry and Toxicology Division, Center for animal Nutrigenomics & Applied Animal Nutrition, Alltech Inc., 3031 Catnip Hill Road, Nicholasville, Kentucky 40356, United States.
Publications dans "Ergotamines" :
2 publications dans cette catégorie
Affiliations :
a Institute of Forensic Medicine , Jena University Hospital , Jena , Germany.
Publications dans "Ergotamines" :
Comparative study on the metabolism of the ergot alkaloids ergocristine, ergocryptine, ergotamine, and ergovaline in equine and human S9 fractions and equine liver preparations.
Xenobiotica; the fate of foreign compounds in biological systems
2019-01-09
Liquid chromatography-mass spectrometry-based determination of ergocristine, ergocryptine, ergotamine, ergovaline, hypoglycin A, lolitrem B, methylene cyclopropyl acetic acid carnitine, N-acetylloline, N-formylloline, paxilline, and peramine in equine hair.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
2019-04-05
2 publications dans cette catégorie
Affiliations :
a Institute of Forensic Medicine , Jena University Hospital , Jena , Germany.
Publications dans "Ergotamines" :
Comparative study on the metabolism of the ergot alkaloids ergocristine, ergocryptine, ergotamine, and ergovaline in equine and human S9 fractions and equine liver preparations.
Xenobiotica; the fate of foreign compounds in biological systems
2019-01-09
Liquid chromatography-mass spectrometry-based determination of ergocristine, ergocryptine, ergotamine, ergovaline, hypoglycin A, lolitrem B, methylene cyclopropyl acetic acid carnitine, N-acetylloline, N-formylloline, paxilline, and peramine in equine hair.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
2019-04-05
2 publications dans cette catégorie
Affiliations :
a Institute of Forensic Medicine , Jena University Hospital , Jena , Germany.
Publications dans "Ergotamines" :
Comparative study on the metabolism of the ergot alkaloids ergocristine, ergocryptine, ergotamine, and ergovaline in equine and human S9 fractions and equine liver preparations.
Xenobiotica; the fate of foreign compounds in biological systems
2019-01-09
Liquid chromatography-mass spectrometry-based determination of ergocristine, ergocryptine, ergotamine, ergovaline, hypoglycin A, lolitrem B, methylene cyclopropyl acetic acid carnitine, N-acetylloline, N-formylloline, paxilline, and peramine in equine hair.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
2019-04-05
2 publications dans cette catégorie
Affiliations :
a Institute of Forensic Medicine , Jena University Hospital , Jena , Germany.
Publications dans "Ergotamines" :
Comparative study on the metabolism of the ergot alkaloids ergocristine, ergocryptine, ergotamine, and ergovaline in equine and human S9 fractions and equine liver preparations.
Xenobiotica; the fate of foreign compounds in biological systems
2019-01-09
Liquid chromatography-mass spectrometry-based determination of ergocristine, ergocryptine, ergotamine, ergovaline, hypoglycin A, lolitrem B, methylene cyclopropyl acetic acid carnitine, N-acetylloline, N-formylloline, paxilline, and peramine in equine hair.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
2019-04-05
1 publication dans cette catégorie
Affiliations :
Division 1.7, Organic Trace and Food Analysis, Bundesanstalt für Materialforschung und-prüfung (BAM), Richard-Willstätter-Str. 11, 12489 Berlin, Germany.
Publications dans "Ergotamines" :
1 publication dans cette catégorie
Affiliations :
Department of Food Chemistry and Toxicology, Technische Universität Berlin, Gustav-Meyer-Allee 25, 13355 Berlin, Germany.
Publications dans "Ergotamines" :
1 publication dans cette catégorie
Affiliations :
Division 1.7, Organic Trace and Food Analysis, Bundesanstalt für Materialforschung und-prüfung (BAM), Richard-Willstätter-Str. 11, 12489 Berlin, Germany.
Publications dans "Ergotamines" :
1 publication dans cette catégorie
Affiliations :
Department of Pathology and Laboratory Medicine, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Publications dans "Ergotamines" :
1 publication dans cette catégorie
Affiliations :
Department of Pathology and Laboratory Medicine, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Publications dans "Ergotamines" :
1 publication dans cette catégorie
Affiliations :
Department of Clinical Immunology and Rheumatology, Kalinga Institute of Medical Sciences, KIIT University, Bhubaneshwar, Odisha, India.
Publications dans "Ergotamines" :
1 publication dans cette catégorie
Affiliations :
Department of Surgical Oncology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Publications dans "Ergotamines" :
1 publication dans cette catégorie
Affiliations :
Department of Urology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Publications dans "Ergotamines" :
1 publication dans cette catégorie
Affiliations :
Department of Gastroenterology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Publications dans "Ergotamines" :
1 publication dans cette catégorie
Affiliations :
Institute for Pharmacology and Toxicology, Medical Faculty, Martin Luther University Halle-Wittenberg, 06120 Halle (Saale), Germany.
Publications dans "Ergotamines" :
1 publication dans cette catégorie
Affiliations :
Institute for Pharmacology and Toxicology, Medical Faculty, Martin Luther University Halle-Wittenberg, 06120 Halle (Saale), Germany.
Publications dans "Ergotamines" :
1 publication dans cette catégorie
Affiliations :
Institute for Pharmacology and Toxicology, Medical Faculty, Martin Luther University Halle-Wittenberg, 06120 Halle (Saale), Germany.
Publications dans "Ergotamines" :
Considerable research has been carried out in the last two decades on the putative benefits of cognitive training on cognitive function and academic achievement. Recent meta-analyses summarizing the e...
Changes in functional brain connectivity (FBC) may indicate how lifestyle modifications can prevent the progression to dementia; FBC identifies areas that are spatially separate but temporally synchro...
DNA methylation as a biomarker is well suited to investigate dynamic processes, such as symptom improvement. For this study we focus on epigenomic state or trait markers as early signatures of cogniti...
Data from a randomized controlled trial (RCT) were used for this analysis, where cognitive function of 112 patients randomly assigned to a personalized cognitive intervention was compared to standard ...
Analyses at baseline and at week 8 did not show any genome-wide significant CpGs (p < 5 × 10...
Our result suggest that DNA methylation can be suitable to capture early signs of treatment response of a cognitive intervention in depression. In our layered approach we could capture dynamics that c...
Amnestic mild cognitive impairment (aMCI) is a risk factor for Alzheimer's disease (AD). Multi-domain cognitive training (CT) may slow cognitive decline and delay AD onset. However, most work involves...
Sensory processing sensitivity (SPS) is a biological trait associated with enhanced awareness of and responsivity to the environment, as well as depth of cognitive processing. However, only a few stud...
Digital cognitive training can remediate cognitive deficits present in schizophrenia. However, limited motivation and engagement may impact adherence to training. Therefore, identifying factors that m...
We measured cognition, symptom severity, motivation (semi-structured interview), and engagement (adapted Utrecht Work Engagement Scale - UWES) of 27 patients with schizophrenia after a 40-h digital co...
The facilitator 'good performance' and the barrier 'difficult exercise' were associated with larger gains in attention (p = 0.03) and reasoning and problem solving (p = 0.02), respectively. 'Poor perf...
Using a mixed quantitative and qualitative research design, we showed associations between motivation and engagement and the response to digital cognitive training in schizophrenia. Facilitators and b...
Cognitive impairment in Parkinson's disease (PD), especially in patients with mild cognitive impairment (PD-MCI), coincides with less physical activity. Cognitive trainings (CT) have been found to pro...
Eighteen patients with PD-MCI of the TrainParC study were analyzed. Those patients received either a 6-week multidomain group CT or physical training (PT). Physical activity and sedentary behavior wer...
Patients in the CT group displayed significantly greater increases in active periods after training than patients assigned to PT. In the CT group, increases in executive functioning were associated wi...
Study data revealed that CT can increase physical activity in patients with PD-MCI, possibly due to effects on executive functions, which needs further investigation in larger sample sizes. Lower work...
Epidemiological evidence suggests that both poor cardiovascular fitness and low muscle mass or strength markedly increase the rate of cognitive decline and incident dementia in older adults. Results f...
One hundred and sixty community-dwelling older (≥ 60 years) people with MCI have been randomised into the trial. Interventions are delivered supervised 2-3 days per week for 12 months. The primary out...
Ethical approval was obtained from the University of Sydney (HREC Ref.2017/368), University of Queensland (HREC Ref. 2017/HE000853), University of British Columbia (H16-03309), and Vancouver Coastal H...
ACTRN12617001440314 Australian New Zealand Clinical Trials Registry....
The increase in population aging highlights the growing prevalence of mild cognitive impairment, prompting the adoption of interventions that combine physical exercise and cognitive training to improv...
A 12-week randomized controlled clinical trial involving 95 participants (aged 72.12 ± 4.25 years), 47 individuals participated in a control group (CG) that only underwent cognitive stimulation, while...
The results of the study show significant improvements in both physical and cognitive aspects, such as balance, gait, upper and lower body strength, flexibility, physical function, cognitive function,...
A combined program for older individuals with mild cognitive impairment leads to enhancements in physical and cognitive health. These improvements underscore the importance of integrating physical exe...
NCT05503641....
Cognitive training is a non-drug intervention to improve the cognitive function of participants by training them in different cognitive domains. We investigated the effectiveness of cognitive training...
Systematic review and meta-analysis....
PubMed, Embase, Cochrane Library, WOS, CINAHL, CNKI, VIP, SinoMed, Wanfang, Grey literature and trial registries were searched (from inception to 1 October 1, 2022)....
Inclusion of randomized controlled trials (RCTs) assessing the effects of cognitive training on breast cancer patients reporting cognitive changes The primary outcome was subjective cognitive function...
Two reviewers worked independently to screen the literature, extract data, and assess the methodological quality and risk bias of the included studies. Results are reported as standardizedstandardised...
The primary outcome was subjective cognitive function. Secondary outcomes were objective cognitive functioning (eg, executive functioning and attention) and psychological outcomes(eg, anxiety, depress...
A total of 9 RCTs involving 666 patients with breast cancer were included. The frequency of cognitive training varied and the duration was mostly focused on 5-12 weeks. It can be delivered to patients...
Evidence of low to moderate certainty suggests that cognitive training may improve subjective cognition, processing speed, verbal memory, working memory and episodic memory in patients with breast can...
CRD42021264316....